Turnover—
EBIT margin—
Net result€-295k+11.1%
Working capital€1.14M+543.1%
Conclusion
the dossier summarised in one paragraphThe computed 12-month bankruptcy probability of BIO INX is 1.2% (low). The 2024 annual accounts show equity of €49k and a net result of €-295k. Its solvency ranks better than 25% of 52 sector peers (fiscal year 2024). The company has been active since 2022 and the Belgian State Gazette contains no insolvency or warning signals.
Based on the State Gazette, CBE and 2 annual accounts.
Bankruptcy probability (12 mo)
Checked model v1 · free for everyone1.2%
Low
0%0,5%1,5%4%10%≥25%
Young company
+Lower-failure-rate sector
−Annual accounts: weaker financial profile
+
Statistical estimate based on public sources — not credit advice nor a finding of fact. How do we compute this?
Financials
FY 2024
€49k
equity
Turnover—
Net result€-295kHealth40/100 · Weak
See full annual accounts
People & board
No director data processed yet.
To directors Publicationslatest 24-10-2024
3
publications in the State GazetteCapital increase of €150,000 to €150,000All publications & acts Network & structure
No network or structure data processed.
To structure
Trust signals
3 signalsMore than 3 years active
Founded in 2022 — past the statistically most fragile first 3 years.
No legal incidents
No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad.
Administratively compliant
No FOD Economie strikeouts (UBO, accounts, address, activity).
Administrative Flags
0 events
No administrative flags
Company registry (CBE)
Crossroads BankActivities
Speur- en ontwikkelingswerk op biotechnologisch gebied72101Speur- en ontwikkelingswerk op biotechnologisch gebied72110
Primary activity highlighted.
Names & trade names
| Legal nameNL | BIO INX |
Registered office
Technologiepark-Zwijnaarde 66
9052 Gent, Belgium
Official data from the Crossroads Bank for Enterprises (CBE). Available for every registered company.